Navigation Links
SpectraCell Laboratories Expands Operations in New Facility
Date:10/27/2008

HOUSTON, Oct. 27 /PRNewswire/ -- SpectraCell Laboratories, Inc., announced that it has doubled the size of its facilities. Recently, SpectraCell occupied a 20,000 sq. ft. building that was custom designed for them in 2005. The planned expansion added a second freestanding 20,000 sq. ft. building to the existing campus. The new $3.5 million facility houses SpectraCell's state-of-the-art clinical laboratory operations while the existing building maintains corporate, financial, marketing and administrative functions. The expansion was completed in October of this year.

"Our business has grown at a strong pace over the past few years, as physicians are accepting what research has been demonstrating for a long time - that nutritional deficiencies directly impact health and wellness," says William "Chip" Stanberry, SpectraCell's Chairman and CEO. "As more clients incorporate our specialized laboratory tests into their practices, their patient outcomes improve measurably. As a result, the number of tests performed by us each month has skyrocketed. We outgrew our current building in three years."

SpectraCell is a privately-owned enterprise founded in 1993 by William B. ("Chip") Stanberry, who serves as its Chairman and Chief Executive Officer. The company's number of employees has more than doubled since 2005 and SpectraCell now serves over 3,000 physician clients in 38 states. The new SpectraCell building is located at the Oak Park development in the Westchase Business District in southwest Houston.

About SpectraCell Laboratories - SpectraCell is a CLIA accredited laboratory that services healthcare providers nationwide by providing advanced clinical testing with the patented FIA(TM) (Functional Intracellular Analysis) and LPP(TM) (Lipoprotein Particle Profile) tests.

SpectraCell's FIA(TM) testing is an innovative assessment of a patient's nutritional status. Unlike traditional serum, hair and urine tests, SpectraCell's FIA(TM) evaluates how an individual's white blood cells respond to varied environments of over 30 vitamins, minerals, amino acids and antioxidants. As a result, individual differences in metabolism, age, genetics, health, prescription drug usage, absorption rate and other factors are taken into consideration in determining deficiencies that need to be corrected.

SpectraCell's LPP(TM) tests are the most advanced lipoprotein tests available. Unlike traditional cholesterol tests, SpectraCell's LPP(TM) directly measures the number of several classes of lipoprotein particles providing an accurate assessment of cardiovascular risk.


'/>"/>
SOURCE SpectraCell Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Dr. Wei Sun, PhD, MD Joins SpectraCell Laboratories
2. SpectraCell Laboratories Offers Additional Test for Heart Attack and Stroke Risk
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
5. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
7. Sandia National Laboratories Selects Allscripts Electronic Health Record and Practice Management for Employee Health Center
8. Andrew Lessmans TWC Construction and ProCaps Laboratories Contract With DT Solar to Install a 700 kW Solar Electric System
9. Mesa Laboratories Names New Vice President of Sales and Marketing
10. Caraco Pharmaceutical Laboratories Ltd. Announces Tentative FDA Approval for Generic Zyrtec Chewable(R)
11. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 Second Quarter Earnings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2017)... Tampa, Fla. (PRWEB) , ... June 24, 2017 ... ... Fla., is now offering genetic testing for medications in select Florida and Texas ... of pharmacogenomics. , This new application of genetic testing recognizes the role ...
(Date:6/23/2017)... ... June 23, 2017 , ... The Rhode Island ... Care Management Alerts and Dashboards, an innovative new service enabling healthcare providers to ... Care Management Alerts and Dashboards provide near real-time data about patients admitted to ...
(Date:6/23/2017)... ... June 23, 2017 , ... The Military Officers Association of America (MOAA) announced ... Veterans Affairs, retired Marine Col. Thomas G. Bowman. , Bowman currently serves as the ... an intimacy with the issues and challenges veterans face with the VA. Following a ...
(Date:6/23/2017)... (PRWEB) , ... June 23, 2017 , ... The Aesthetic ... facelift . Dr. Talei has come up with a proprietary technique that he calls ... lifts tissues that have dropped. For all ages, patients can expect to look refreshed, ...
(Date:6/23/2017)... Santa Monica, CA (PRWEB) , ... June 23, 2017 , ... ... PureLife as the endorsed amalgam separator supplier for CDA members. As part of the ... a reduced price of $99, saving more than $400 off the retail value. This ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... ALTO, Calif. , June 9, 2017 ... device company focused on the design, manufacture, sale and ... the market on the progress of its commercial roll-out ... is now available in more than one hundred (100) ... AeroForm offers a needle-free alternative for ...
(Date:6/7/2017)... , June 7, 2017 Endo International ... June 7, 2017, the Hon. Joseph R. Goodwin ... of West Virginia , entered a ... Inc. Pelvic Repair System Products Liability Litigation (the "MDL") ... MDL cases to provide expert disclosures on specific causation ...
(Date:6/3/2017)... -- Eli Lilly and Company (NYSE: LLY ... 3 MONARCH 2 study showed that abemaciclib, a ... with fulvestrant, significantly improved progression-free survival (PFS) compared ... hormone-receptor-positive (HR+), human epidermal growth factor receptor 2-negative ... progressed after endocrine therapy (median PFS, 16.4 vs. ...
Breaking Medicine Technology: